Deep Dive with Lindsay Hill, DNP, PMHNP - Psych NP Mentor - PMHNP Mentor

In this deep-dive episode, we unpack FDA ADHD Stimulant Label Change: Weight Loss Risk PMHNPs Must Know. The FDA now requires all extended-release ADHD stimulants to carry a Limitation of Use warning about weight loss risk in children under 6. Younger kids get higher plasma exposures from ER formulations, leading to clinically significant weight loss (10%+ drop in CDC weight percentile). PMHNPs ne...

In this deep-dive episode, we unpack PMHNP Business Entity: PLLC vs. S-Corp Tax Playbook for 2026. Audio Overview Listen to an in-depth podcast of this post Two hosts break down the full article — no reading required. Your browser does not support audio playback. TL;DR A PMHNP netting $220,000 in a sole-prop PLLC pays ~$9,500 more per year in self-employment tax than one who filed the S-Corp elect...

In this deep-dive episode, we unpack Bysanti (Milsaperidone) FDA Approval: What PMHNPs Need to Know. Bysanti (milsaperidone) is a newly FDA-approved atypical antipsychotic with a unique dual mechanism — partial D2 agonism combined with 5-HT2A inverse agonism — designed to reduce metabolic side effects and EPS risk compared to older atypicals. It’s approved for schizophrenia and bipolar I maintenan...

In this episode of Deep Dive with Lindsay Hill, we tackle a clinical reality that most psychiatric providers aren't yet addressing: millions of patients are using AI chatbots for emotional support and mental health guidance, and they're not telling you about it. Drawing from a recent JAMA Psychiatry paper by Shaddy Saba at NYU, Lindsay breaks down why asking about AI use should become as routine a...

In this episode of Deep Dive with Lindsay Hill, we explore pramipexole (Mirapex) as an evidence-based augmentation strategy for treatment-resistant unipolar depression. Lindsay breaks down the PAX-D trial published in The Lancet Psychiatry, which demonstrated significant symptom reduction at 12 weeks that persisted through 48 weeks when pramipexole was added to existing antidepressants at a target...

In this episode of Deep Dive with Lindsay Hill, we break down the American Psychological Association's first new PTSD guideline in eight years — and why it matters for every PMHNP student sitting for boards or walking into their first clinical rotation. Released in February 2025, this updated Clinical Practice Guideline for the Treatment of Posttraumatic Stress Disorder in Adults expands the evide...

Welcome to Courtrooms, Classrooms, and Clinics , a deep dive into the complex, multidisciplinary realities of supporting autistic adolescents today. In this episode, we explore how the challenges autistic youth face extend far beyond traditional therapy, requiring a unified approach across every aspect of their lives. In the Clinic: We tackle urgent and often misunderstood clinical truths. Did you...

This episode reviews brexpiprazole's expanding FDA indications, including its approval for agitation in Alzheimer's dementia and mixed results in PTSD augmentation. Dr. Amritha Bhat discusses perinatal mental health, covering antidepressant safety in pregnancy, postpartum psychosis as a bipolar spectrum disorder, and zuranolone for postpartum depression. Also featured: new research on service dogs...

In this episode, we dive into the critical field of reproductive psychiatry to equip psychiatric nurse practitioners with the latest evidence-based strategies for managing pregnant and postpartum patients.... Listeners will learn how to differentiate psychiatric emergencies like postpartum psychosis from postpartum obsessive-compulsive disorder, and navigate complex medication decisions involving...

Join this insightful peer consultation session where psychiatric nurse practitioners navigate the complexities of clinical decision-making and private practice dynamics. The group explores the nuances of scope of practice, specifically debating when to manage medical comorbidities like migraines or withdrawal symptoms and the utility of "two-for-one" medications like topiramate. Listeners will gai...

This episode dives into evidence-based strategies for treating Obsessive-Compulsive Disorder when first-line SSRIs fail, exploring augmentation options like ondansetron, memantine, and deep TMS.... We also sit down with Dr. David Jobes to discuss the Collaborative Assessment and Management of Suicidality (CAMS), a transformative framework that empowers patients by focusing on their specific driver...

Dive into the complex landscape of developmental disorders with a comprehensive look at managing Trisomy 21, Fetal Alcohol Spectrum Disorders (FASD), and clinical dysmorphology. We explore the psychiatric comorbidities of Down syndrome, offering evidence-based pharmacologic strategies for treating depression, anxiety, and ADHD while challenging implicit biases that limit patient potential. Expert...

In this episode, we critically evaluate the expanding clinical profile of brexpiprazole, analyzing its recent FDA approval for agitation in Alzheimer’s dementia alongside the data behind its rejection for PTSD. We dive into perinatal mental health with Dr. Amritha Bhat, who offers expert guidance on navigating the risk-benefit analysis of psychotropics during pregnancy, the use of zuranolone, and...

This episode explores the transformative power of integrating wellness-centric interventions into psychiatric practice, moving beyond mere symptom reduction to the cultivation of true mental well-being.... Listeners will discover the neurobiology behind the "HERO" traits—Happiness, Enthusiasm, Resilience, and Optimism—and how specific lifestyle interventions like the WILD 5 Wellness program can ta...

This episode equips psychiatric nurse practitioners with advanced strategies for managing complex withdrawal syndromes and identifying medical mimics in clinical practice. Listeners will explore evidence-based protocols for treating buprenorphine-precipitated withdrawal—including the efficacy of administering additional buprenorphine—and review a novel inpatient pathway for methamphetamine withdra...

In this episode, we explore culturally competent assessment strategies with Dr. Dakota Carter, demonstrating how to bridge Western medicine with diverse family beliefs through the lens of a First-Generation youth case study. We also dive into Neuroscience-Based Nomenclature (NbN), a pharmacological classification system that reduces stigma and improves patient education regarding off-label prescri...

In this episode, we uncover the high rates of misdiagnosis in Fetal Alcohol Spectrum Disorders (FASD) and provide specific screening questions, such as the "4Ps Plus" method, to improve detection in your clinical practice. We dive into the psychiatric management of Trisomy 21, outlining appropriate pharmacologic interventions for comorbidities like anxiety, ADHD, and autism-related irritability wh...

This episode provides a comprehensive guide to managing complex psychiatric challenges in autistic youth, specifically addressing irritability, suicidality, and psychosis. We explore a step-by-step treatment algorithm for irritability that prioritizes functional goals and evidence-based off-label pharmacotherapy, such as guanfacine, memantine, and low-dose naltrexone, to help you avoid premature e...

🧠 Brain Energy: The "Cliff Notes" Version ⚡ 🚨 The Big Reveal Hold onto your neurons—Dr. Christopher Palmer is flipping the script. The central thesis is a game-changer: Mental disorders are not just chemical imbalances or psychological issues; they are metabolic disorders of the brain . Whether it's anxiety, depression, ADHD, or schizophrenia, the root cause traces back to the same biological p...

In this episode, we explore the addiction treatment continuum to help you determine when to prioritize pharmacotherapy versus psychotherapy for opioid, stimulant, and alcohol use disorders. We provide a deep dive into Brixadi, a new long-acting injectable buprenorphine, comparing its weekly and monthly dosing options to Sublocade and discussing its potential role in rapid induction protocols34. Ex...

Episode Description Imagine sending your 10-year-old to live on Mars. They aren't evolved for the low gravity, the alien environment, or the isolation. According to social psychologist Jonathan Haidt, this is exactly what we did to Generation Z when we traded a "play-based childhood" for a "phone-based childhood" in the early 2010s. In this episode, we dive into Haidt’s The Anxious Generation to u...

Join us as we explore the critical medical complications of eating disorders through the lens of Dr. Jennifer Gaudiani’s "Sick Enough," a vital resource for psychiatric nurse practitioners managing the intersection of mental and physical health. We examine the physiological impacts of starvation and purging, including "cave person brain" adaptations, hypoglycemia, and the dangerous fallacy of rely...

This episode explores the critical crisis of healthcare worker burnout and mental health through the lens of Dr. Jessi Gold's clinical work with medical professionals during the pandemic,,. We discuss tailored treatment strategies for high-functioning clinicians, including the use of SSRIs like sertraline for OCD, beta-blockers for performance anxiety, and the integration of Exposure and Response...

Show Notes: How Do You Feel? – One Doctor’s Search for Humanity in Medicine In this episode, we dive into the poignant and revealing memoir How Do You Feel? by psychiatrist Dr. Jessi Gold. What happens when the people trained to save our lives are the ones who need saving? Dr. Gold takes us behind the scenes of her clinic, where she specializes in treating healthcare workers—a group often celebrat...

Explore the intersection of high achievement and severe mental illness through the case of Elyn Saks, a tenured law professor living with schizophrenia.... We examine her clinical trajectory from a "grave" prognosis to professional success, analyzing her treatment regimen involving antipsychotics like thiothixene and clozapine combined with long-term psychoanalysis.... The discussion highlights th...